16. Cervix cancer - The GEC-ESTRO Handbook of Brachytherapy

Cervix cancer

27

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 01/09/2023

Figure 26. EMBRACE-I bladder/urinary morbidity: (A) Physician-assessed prevalence and actuarial cumulative incidence and (B) patient-reported outcomes prevalence (Reprinted from Radiother. Oncol., 127/3, Fokdal L, Pötter R, Kirchheiner K, et al., Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer, 423-430, 2018, with permission from Elsevier).

Figure 27. Dose effect relationship of combined EBRT and BT dose to the rectovaginal reference point and vaginal stenosis G≥2 (Reprinted from Radiother. Oncol., 118/1, Kirchheiner K, Nout RA, Lindegaard JC, et al., Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study, 160-166, 2016, with permission from Elsevier).